Follow real-time updates on Union Budget 2023Catch exclusive videos on Union Budget 2023 from CNBC-TV18
Centre is examining ways to tackle the challenges such as how to verify claims about the use of locally sourced APIs.
The government may bring a proposal to remove drugs made from local ingredients out of price control list, reported Mint, citing two senior government officials. However, drugs made from imported APIs will remain under the drug price control order, it added.
Recommended ArticlesView All
World Cancer Day 2023: Early detection is crucial for reducing the global burden
Feb 4, 2023 IST5 Min(s) Read
World Cancer Day 2023: A way forward to better management of cancer this year!
Feb 4, 2023 IST6 Min(s) Read
Pakistan economy at alarming level as foreign reserves drop to $3.1 billion from $16.6 billion in a year
Feb 3, 2023 IST3 Min(s) Read
FM Nirmala Sitharaman speaks on inflation, taxes, GDP and more. Read the full interview here
Feb 3, 2023 IST37 Min(s) Read
The move is aimed at reducing the dependence of Indian companies on imports and a committee led by Mansukh Lal Mandaviya, minister of state for chemicals and fertilizers last month, has been formed to look into ways to boost bulk drug manufacturing in India, the officials told Mint on condition of anonymity.
The development, the report said, will be crucial for the supply of APIs, or bulk drugs, that are the raw material from which medicines are manufactured. While currently, China is the source of the bulk of the API’s, the new decision could change the situation.
The Centre is also looking at challenges such as how to verify claims about the use of locally sourced APIs. Moreover, changing the drug price control order is also a challenge, noted the report.